Skip to main content
    S

    Skye Bioscience, Inc. Common Stock (SKYE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.06
    -0.03 (-2.29%)

    Market Cap: $4.83M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Skye Bioscience, Inc. Common Stock (SKYE) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Skye Bioscience, Inc. Common Stock (SKYE) to earn -$5.04 per share in the fiscal year ending Dec 31, 2026. Of 4 analysts, 2 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Hold. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$6.67.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 50% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy250.0%
    Hold250.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss.

    Fiscal year ending Dec 31, 2026
    -$5.04
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$6.67
    EPS consensus
    Next report
    Mar 8, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$5.04-$5.04 to -$5.041
    Dec 31, 2027-$6.67-$10.80 to -$4.563

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$1.09-$1.18 to -$0.925

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$8.37.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$5.04-$5.04-$5.04-$5.04-$8.37N/A
    Fiscal year ending Dec 31, 2027-$6.67-$7.40-$7.40-$7.40-$9.05N/A

    Frequently Asked Questions About SKYE

    What is the SKYE stock forecast?

    Consensus analyst estimates put Skye Bioscience, Inc. Common Stock's EPS at -$5.04 for the fiscal year ending Dec 31, 2026. The consensus rating from 4 analysts is Hold.

    How do analysts rate SKYE stock?

    Of 4 analysts covering Skye Bioscience, Inc. Common Stock, 0 rate it Strong Buy, 2 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from SKYE next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$5.04, with estimates from -$5.04 to -$5.04 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$6.67, with estimates from -$10.80 to -$4.56 from 3 analysts.

    How many analysts cover SKYE?

    4 analysts rate Skye Bioscience, Inc. Common Stock stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.